Chief Executive Officer
Andrew has more than 20 years research and industry experience, has held local and global roles in R&D in large pharmaceutical companies, early phase research institutions, and successfully led business development activities for a global contract research organisation. He has expertise in the development and operational delivery of global clinical activities across Asia Pacific, Europe, Africa and North America. He is passionate about the development of new medicines for diseases of unmet medical needs and spent several years working on clinical trials for malaria and tuberculosis vaccines. He is a Non-Executive Director on the board of a not-for-profit organisation that supports research into treatments and a cure for a rare neurological disease.
A skills-based board combines comprehensive experience in academic research, financial strategy, commercial development and biotechnology & pharmaceutical industries. Along with the specialised leadership team, this expertise drives Doherty Clinical Trials Ltd unique capabilities.